Bausch Health (STU:BVF) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BVF Bausch Health Companies Inc STU:BVF
67 GF Score
Price €4.89
GF Value €6.50
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bausch Health Unearned Premiums?

Unearned Premiums only applies to insurance companies.

STU:BVF
67GF Score
Bausch Health Companies Inc STU:BVF
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (STU:BVF) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of €4.89 is trading 24.8% below its estimated GF Value™ of €6.50. GuruFocus considers Bausch Health to be Modestly Undervalued.

Key valuation signals for STU:BVF:

  • Unearned Premiums:
  • GF Value™: €6.50 vs. price of €4.89 (24.8% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the STU:BVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
67GF Score

Get the complete analysis for STU:BVF

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.89
Price
€6.50
GF Value